COMP <GO>
HP vs CVX // ALTMAN Z-SCORE & DEBT/EQUITY
Helmerich & Payne Inc. (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: HP 4
— CVX 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: CVX
LAST: $42.99 (+3.39%) • MKT CAP: $4.16B
balance-sheet
2.05
LAST: $235.52 (+1.75%) • MKT CAP: $457.31B
balance-sheet
3.71
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HP VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HP | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.30% | -0.30 | CVX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.10% | 5.80% | -5.70 | CVX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.2x | 21.5x | -5.30 | HP | /valuation <GO> |
| Free Cash Flow Yield | 2.81% | 5.61% | -2.80 | CVX | /fcf-yield <GO> |
| Operating Margin | 0.10% | 8.10% | -8.00 | CVX | /operating-margins <GO> |
| Net Profit Margin | -4.40% | 6.70% | -11.10 | CVX | /net-margins <GO> |
| Revenue Growth (YoY) | 34.00% | -4.60% | +38.60 | HP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.42% | 2.79% | -0.37 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.05 | 3.71 | -1.66 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.10% | -0.20 | HP | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 72.8 | -7.48 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 1.07 | -0.07 | CVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 34.6x | -16.60 | HP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.16B | $457.31B | -$453.16B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HP REV | CVX REV | HP GROSS % | CVX GROSS % | HP FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.68B | $184.43B | 44.0% | 41.3% | $116.6M | $25.64B |
| FY 2024 | $2.75B | $193.41B | 44.0% | 38.4% | $189.6M | $22.79B |
| FY 2023 | $2.86B | $196.91B | 44.0% | 44.0% | $704.9M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HP // BETA 1.00
CVX // BETA 1.07